RankAlpha logo
Back to Rankings

CRSP

CRISPR TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
CRSP vs peer average
66/100
CRSP vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

DYN is the first available peer comparator.

Mid-cap clinical-stage biotech with platform and development risk; a useful volatility comparator, but its programs and indications differ materially from CRSP.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerDYNDyne Therapeutics
CRSP
CRISPR Therapeutics
DYN
Dyne Therapeutics
Grade
B
F
Momentum
51
24
Value
41
41
Sentiment
82
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs DYN

CRSP / DYN
Grade Position
In line
CRSP vs. peer average (B vs. C)
66/100
Momentum
51
CRSP
Value
41
CRSP
Sentiment
82
CRSP

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CRSP
1
DYN
DYN
F
20/100
+3
2
EWTX
EWTX
D
40/100
+2
3
ACAD
ACAD
B
80/100
Even
4
SHC
Sotera Health Co Common
B
80/100
Even
5
STVN
Stevanato Group SpA Common
C
60/100
+1
DYN is the first peer returned for this comparison set.